• 474 Citations
  • 12 h-Index
20062018
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2011 PhD, Institute of Clinical Pharmacy and Pharmaceutical Sciences , National Cheng Kung University

Experience

  • 2011-2012, Postdoctoral Fellow/Department of Biochemistry and Molecular Biology, National Cheng Kung University
  • 2012-present, Research Fellow/Antibody New Drug Development Center, National Cheng Kung University
  • 2013-2015, Adjunct Assistant Professor/Department of Biochemistry and Molecular Biology, National Cheng Kung University
  • 2015-present, Assistant Professor/Institute of Clinical Medicine, National Cheng Kung University

Research Interests

  • Cytokine regulation
  • Osteoimmunology
  • New antibody drug development

Fingerprint Dive into the research topics where Yu-Hsiang Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Interleukins Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Experimental Arthritis Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
Osteolysis Medicine & Life Sciences
interleukin 20 Medicine & Life Sciences
Cytokines Medicine & Life Sciences
Bone Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2018

Research Output 2006 2018

  • 474 Citations
  • 12 h-Index
  • 19 Article
  • 4 Review article
1 Citation (Scopus)

IL-20 bone diseases involvement and therapeutic target potential

Wang, H. H., Hsu, Y-H. & Chang, M-S., 2018 Apr 24, In : Journal of biomedical science. 25, 1, 38.

Research output: Contribution to journalReview article

Bone Diseases
Bone
Bone and Bones
Osteolysis
Osteogenesis

The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis

Huang, K., Hsu, Y., Chen, W., Tsai, H., Yan, J., Wang, J., Liu, W. & Lin, R., 2018 Dec 1, In : Journal of Inflammation. 15, 1

Research output: Contribution to journalArticle

5 Citations (Scopus)

Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis

Hsu, Y-H., Yang, Y. Y., Huwang, M. H., Weng, Y. H., Jou, I. M., Wu, P-T., Lin, T. Y., Wu, L-W. & Chang, M-S., 2017 Apr 1, In : PLoS ONE. 12, 4, e0175802.

Research output: Contribution to journalArticle

osteoarthritis
Cartilage
interleukins
cartilage
Osteoarthritis

Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma

Chiu, Y. S., Hsing, C. H., Li, C. F., Lee, C. Y., Hsu, Y-H. & Chang, M-S., 2017 Dec 1, In : Scientific reports. 7, 1, 17609.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Monoclonal Antibodies
Growth
Cyclin D1
Neoplasms
5 Citations (Scopus)

IL-20 in rheumatoid arthritis

Hsu, Y-H. & Chang, M-S., 2017 Jun 1, In : Drug Discovery Today. 22, 6, p. 960-964 5 p.

Research output: Contribution to journalReview article

Rheumatoid Arthritis
Osteitis
Autoimmune Diseases
Joints
Clinical Trials

Thesis

The regulatory role of IL-29 on osteoblasts and osteoclasts

Author: 芳旭, 陳., 2018 Sep 1

Supervisor: Hsu, Y. (Supervisor)

Student thesis: Master's Thesis

The role of IL-29 in adipocyte-macrophage crosstalk

Author: 恬毓, 林., 2017 Aug 18

Supervisor: Hsu, Y. (Supervisor)

Student thesis: Master's Thesis